These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25297985)

  • 21. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells.
    Hoerstrup SP; Kadner A; Melnitchouk S; Trojan A; Eid K; Tracy J; Sodian R; Visjager JF; Kolb SA; Grunenfelder J; Zund G; Turina MI
    Circulation; 2002 Sep; 106(12 Suppl 1):I143-50. PubMed ID: 12354724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Microencapsulated VEGF gene-modified umbilical cord mesenchymal stromal cells promote the vascularization of tissue-engineered dermis: an experimental study.
    Han Y; Tao R; Han Y; Sun T; Chai J; Xu G; Liu J
    Cytotherapy; 2014 Feb; 16(2):160-9. PubMed ID: 24438897
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The potential of 3-dimensional construct engineered from poly(lactic-co-glycolic acid)/fibrin hybrid scaffold seeded with bone marrow mesenchymal stem cells for in vitro cartilage tissue engineering.
    Abdul Rahman R; Mohamad Sukri N; Md Nazir N; Ahmad Radzi MA; Zulkifly AH; Che Ahmad A; Hashi AA; Abdul Rahman S; Sha'ban M
    Tissue Cell; 2015 Aug; 47(4):420-30. PubMed ID: 26100682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs.
    Sarig U; Nguyen EB; Wang Y; Ting S; Bronshtein T; Sarig H; Dahan N; Gvirtz M; Reuveny S; Oh SK; Scheper T; Boey YC; Venkatraman SS; Machluf M
    Tissue Eng Part A; 2015 May; 21(9-10):1507-19. PubMed ID: 25602926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Accelerating the early angiogenesis of tissue engineering constructs in vivo by the use of stem cells cultured in matrigel.
    Schumann P; Lindhorst D; von See C; Menzel N; Kampmann A; Tavassol F; Kokemüller H; Rana M; Gellrich NC; Rücker M
    J Biomed Mater Res A; 2014 Jun; 102(6):1652-62. PubMed ID: 23776037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Viable osteogenic cells are obligatory for tissue-engineered ectopic bone formation in goats.
    Kruyt MC; de Bruijn JD; Wilson CE; Oner FC; van Blitterswijk CA; Verbout AJ; Dhert WJ
    Tissue Eng; 2003 Apr; 9(2):327-36. PubMed ID: 12740095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineering Pre-vascularized Scaffolds for Bone Regeneration.
    Barabaschi GD; Manoharan V; Li Q; Bertassoni LE
    Adv Exp Med Biol; 2015; 881():79-94. PubMed ID: 26545745
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-inflammatory/tissue repair macrophages enhance the cartilage-forming capacity of human bone marrow-derived mesenchymal stromal cells.
    Sesia SB; Duhr R; Medeiros da Cunha C; Todorov A; Schaeren S; Padovan E; Spagnoli G; Martin I; Barbero A
    J Cell Physiol; 2015 Jun; 230(6):1258-69. PubMed ID: 25413299
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia-inducible factor 1 alpha contributes to cardiac healing in mesenchymal stem cells-mediated cardiac repair.
    Cerrada I; Ruiz-Saurí A; Carrero R; Trigueros C; Dorronsoro A; Sanchez-Puelles JM; Diez-Juan A; Montero JA; Sepúlveda P
    Stem Cells Dev; 2013 Feb; 22(3):501-11. PubMed ID: 22873764
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improved microvascular network in vitro by human blood outgrowth endothelial cells relative to vessel-derived endothelial cells.
    Sieminski AL; Hebbel RP; Gooch KJ
    Tissue Eng; 2005; 11(9-10):1332-45. PubMed ID: 16259589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineering vascularized bone: osteogenic and proangiogenic potential of murine periosteal cells.
    van Gastel N; Torrekens S; Roberts SJ; Moermans K; Schrooten J; Carmeliet P; Luttun A; Luyten FP; Carmeliet G
    Stem Cells; 2012 Nov; 30(11):2460-71. PubMed ID: 22911908
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endothelialization approaches for viable engineered tissues.
    Baiguera S; Ribatti D
    Angiogenesis; 2013 Jan; 16(1):1-14. PubMed ID: 23010872
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The delayed addition of human mesenchymal stem cells to pre-formed endothelial cell networks results in functional vascularization of a collagen-glycosaminoglycan scaffold in vivo.
    McFadden TM; Duffy GP; Allen AB; Stevens HY; Schwarzmaier SM; Plesnila N; Murphy JM; Barry FP; Guldberg RE; O'Brien FJ
    Acta Biomater; 2013 Dec; 9(12):9303-16. PubMed ID: 23958783
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive effect of mesenchymal stem cells and VEGF to vascularization of PLGA scaffolds.
    Kampmann A; Lindhorst D; Schumann P; Zimmerer R; Kokemüller H; Rücker M; Gellrich NC; Tavassol F
    Microvasc Res; 2013 Nov; 90():71-9. PubMed ID: 23899416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Flap prefabrication and prelamination with tissue-engineered cartilage.
    Staudenmaier R; Hoang TN; Kleinsasser N; Schurr C; Frölich K; Wenzel MM; Aigner J
    J Reconstr Microsurg; 2004 Oct; 20(7):555-64. PubMed ID: 15534783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of whole bone marrow, whole bone marrow cultured cells, and mesenchymal stem cells in chronic wound healing.
    Rodriguez-Menocal L; Shareef S; Salgado M; Shabbir A; Van Badiavas E
    Stem Cell Res Ther; 2015 Mar; 6(1):24. PubMed ID: 25881077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomaterial-mesenchymal stem cell constructs for immunomodulation in composite tissue engineering.
    Hanson S; D'Souza RN; Hematti P
    Tissue Eng Part A; 2014 Aug; 20(15-16):2162-8. PubMed ID: 25140989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of outgrowth endothelial cells from human peripheral blood on in vivo vascularization of bone tissue engineered constructs based on starch polycaprolactone scaffolds.
    Fuchs S; Ghanaati S; Orth C; Barbeck M; Kolbe M; Hofmann A; Eblenkamp M; Gomes M; Reis RL; Kirkpatrick CJ
    Biomaterials; 2009 Feb; 30(4):526-34. PubMed ID: 18977026
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow-derived mesenchymal stem cells become antiangiogenic when chondrogenically or osteogenically differentiated: implications for bone and cartilage tissue engineering.
    Bara JJ; McCarthy HE; Humphrey E; Johnson WE; Roberts S
    Tissue Eng Part A; 2014 Jan; 20(1-2):147-59. PubMed ID: 23895198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Engineering vascularised tissues in vitro.
    Rivron NC; Liu J J; Rouwkema J; de Boer J; van Blitterswijk CA
    Eur Cell Mater; 2008 Feb; 15():27-40. PubMed ID: 18288631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.